News

Circulating oxysterol levels

A new tool in detecting breast cancer
Kian Kamgar-Parsi
May 01, 2019

In an article in the journal Clinical Chemistry and Laboratory Medicine, F. Peter Guengerich of the Vanderbilt School of Medicine and an international team showed a correlation between certain circulating molecules and the presence of cancerous cells.

Lab techFinding cancer before it has progressed or spread is crucial when trying to fight the disease. Despite this, early cancer detection remains a challenge. Cancers often can lie undetected without symptoms until it’s too late for effective treatment. Recent research, however, may present a new path to overcoming this obstacle.

Oxygenated metabolites of cholesterol, called oxysterols, are molecules formed naturally through metabolic processes and play important roles in mediating cholesterol and lipid metabolism. By measuring the blood levels of oxysterols in breast cancer patients before and after tumor removal, Guengerich and colleagues discovered that certain concentrations changed, indicating a potential role for them in cancer biology.

“In general, some people think that most cancer is caused by things in the environment, like smoking or the things they eat,” Guengerich said. “Turns out there’s a lot of stuff going on in our own bodies, like metabolism, that’s driving cancer.”

Oxysterols have been implicated in breast cancer in the past, but this new research indicates that their role may be more complex than previously thought. While researchers have known for years that there are multiple types of oxysterols, it turns out that these oxysterols can behave very differently from each other when tumors grow and are removed.

Particularly surprising to Guengerich and his team was that one oxysterol, 7-ketocholesterol, or 7-keto, actually decreased in concentration when tumors grew and increased in concentration after tumors were removed. Previously, many scientists believed that more cancer would mean more oxysterols.

“Even in this field, people have the idea that all oxysterols are bad, but our work indicates that that may not be true,” said Guengerich, who is a deputy editor of the Journal of Biological Chemistry. “Levels of individual oxysterols are going up and down in relation to a cancer, so they’re not necessarily all good or all bad, but all have their own type of biology.”

This richer picture of oxysterol behavior gives rise to the hope that the monitoring of oxysterols could become an early warning system for cancer, although Guengerich warns that we’re not there yet. Studies are needed to determine how oxysterol levels change after tumor removal and how those changes correlate with survival rates. Researchers also want to determine if changes in oxysterols indicate cancer metastasis.

This research project was limited; only 24 patients were involved and the study lacked healthy control subjects for comparison. “Cancer is a heterogeneous type of disease, and we need more people and time to be clinically useful,” Guengerich said.

Oxysterols such as 7-keto may not yet be useful biomarkers, but they present a promising avenue of research and raise new questions: What causes the change in oxysterol levels? Are these changes a cause of breast cancer or a side effect? When answers are found, they could lead to new tools in the fight against breast cancer.

Kian Kamgar-Parsi

Kian Kamgar-Parsi studied biophysics at the University of Michigan and is a consultant for the pharmaceutical industry.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

A small army of researchers races to build a coronavirus interactome
News

A small army of researchers races to build a coronavirus interactome

April 01, 2020

Scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.

Parkinson's  Awareness Month
Health Observance

Parkinson's Awareness Month

April 01, 2020

It is the second-most common progressive neurodegenerative disease, occurring in 1% of people over the age of 60 and in 5% of people over 85.

Multiomics meets antimalarials
Journal News

Multiomics meets antimalarials

March 31, 2020

Researchers in Australia use an innovative multiomics approach to analyze a new drug against malaria parasites.

From the journals: JLR
Journal News

From the journals: JLR

March 31, 2020

Topics include the role of HDL and Smo in inhibiting beta-cell apoptosis, lipid asymmetry in a plasma membrane and apolipoproteins and dementia risk.

Researchers retool genomics labs to provide COVID-19 testing
News

Researchers retool genomics labs to provide COVID-19 testing

March 30, 2020

The pipetting robots are already in place, but that doesn’t make it easy. Here's how academic laboratories are quickly pivoting to provide testing for the coronavirus.

Research on a budget
Essay

Research on a budget

March 30, 2020

As a professor at a small university, Peter Lyons has developed ways of reaching his research goals with limited funding, and he shares some of them here.